logo-loader
viewCallitas Health Inc

M Pharma's Gary Thompson 'excited' to receive US Extrinsa trademark

Gary Thompson, president and chief executive of M Pharmaceutical Inc (CSNX:MQ, OTCMKTS:MPHMF) tells Proactive they've received an official trademark for Extrinsa from the US patent office.

The treatment is a solution for female sexual dysfunction (FSD).

Quick facts: Callitas Health Inc

Price: - CAD

CSE:LILY
Market: CSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc named herein, including the promotion by the Company of Callitas Health Inc in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Callitas Health expects to roll out 'ToConcieve' product in the fourth quarter

Callitas Health (CSE:LILY, OTCQB:MPHMF, OTCMKTS: MPHMF) CEO James Thompson tells Proactive Investors that the clinical-stage pharmaceutical company is working through the R&D phase to get its ToConceive product onto retail shelves by the fourth quarter. In March, Callitas announced a...

on 12/7/18

2 min read